Interview with Stefan Dr. Walzer: Revolutionizing Healthcare Market Access with AI
Stefan Walzer
CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH
Location: Germany
In this interview, Stefan Dr. Walzer, CEO of MArS Market Access & Pricing Strategy GmbH, shares insights into their AI-driven initiatives aimed at transforming healthcare market access. He discusses the inspiration behind projects like Q-BO and mAxInsights, highlighting their objectives to streamline processes, reduce costs, and enhance decision-making in healthcare. Stefan explores the challenges faced, strategies for successful adoption, and offers advice for aspiring leaders on driving innovation in their industries.
What drove the development of your most recent business initiative?
The inspiration for our latest projects, including Q-BO, DO-Bo, Wafle, and mAxInsights (see https://marketaccess4-0.com), stemmed from the pressing need to streamline and enhance the efficiency of market access processes in healthcare. Our main objectives were to leverage advanced AI technologies to simplify complex tasks such as creating objection handlers, reimbursement dossiers, and market access insights. We aimed to provide our clients with powerful tools that save time, reduce costs, and improve the accuracy and quality of their work.
Do you have a proprietary platform, and if so, could you describe its main features?
Yes, we have developed several proprietary platforms, each tailored to address specific needs within the healthcare market access space. Our key platforms are mAxInsights, DO-BO, Q-BO and Wafle. Each platform leverages advanced artificial intelligence to deliver unique and powerful capabilities:
mAxInsights:
· Comprehensive Market Access Information: Provides early payer clinical assessments, reimbursement codes, epidemiology data, and reimbursement pathways.
· Real-Time Updates: Ensures users have the most current and relevant information.
· Market Access Plan in a fingertip
DO-BO:
· Reimbursement Dossier Creation: Generates detailed dossiers for reimbursement agencies such as the US AMCP, EU joint clinical assessment, German AMNOG in minutes.
· Secure Back-End: Ensures the confidentiality and security of sensitive healthcare data.
· Compliance and Accuracy: Tailored for the nuanced field of healthcare reimbursement.
Q-BO:
· AI-Driven Objection Handling: Creates comprehensive and tailored objection handlers within minutes.
· Customizable Responses: Adaptable to specific scenarios and requirements.
· User-Friendly Interface: Intuitive design for ease of use.
· Training conversation with text only or audio-in / audio-out.
Wafle:
· Innovative Uses of Virtual Reality combined with artificial intelligence in health care
· The future of training for health care negotiations.
· Leverage VR to train any team more effectively including key accounts and sales representatives
· Data Security and Privacy: Addressing the crucial aspects of data security and privacy in the virtual realm.
Each of these platforms is designed to address specific pain points in the market access process, enhancing efficiency, accuracy, and strategic insight for our clients. By integrating cutting-edge AI technology with a deep understanding of the healthcare industry, our proprietary platforms are transforming the way market access professionals work.
2. Can you describe a significant challenge you faced during this endeavor?
One of the most significant challenges we faced was ensuring the security and privacy of sensitive healthcare data while developing our AI platforms. To navigate this, we implemented robust data encryption and latest processes which have also been used in the past with AI platforms within the FinTech area. This meticulous approach helped us build a secure and trustworthy platform for our users.
3. What long-term benefits do you anticipate?
I foresee our platforms revolutionizing the market access landscape in healthcare by significantly reducing the time and effort required for critical processes – I believe all of our platforms are disruptive! Long-term, we anticipate that these tools will enable more strategic decision-making and enhance the overall efficiency and effectiveness of market access teams. By automating routine tasks, professionals can focus more on strategic activities that drive better health outcomes and business results.
4. What strategies did you employ to ensure the successful launch and adoption ?
To ensure a successful launch and adoption, we employed a multifaceted strategy that included extensive training sessions, user-friendly interfaces, and comprehensive support systems. We also gathered continuous feedback from early users to refine and improve our platforms. By demonstrating the tangible benefits and ease of use, we ensured our team and clients were confident in adopting these new technologies.
5. What advice would you give to aspiring business leaders looking to innovate and drive change in their industries?
My advice to aspiring business leaders is to stay relentlessly focused on solving real problems and to leverage technology as a powerful enabler of change. Innovation requires a clear vision, but also a willingness to adapt and iterate based on feedback and changing circumstances. Build a strong, diverse team and foster a culture of collaboration and continuous improvement. Most importantly, never lose sight of the value you aim to create for your customers and the broader industry.
Thank you, Stefan!
